Skip to main content
OpenTrials
Completed

NCT Number: NCT00824603

Impact of Continuing Medical Education (CME) Insulin Program

The purpose of this study is to determine if a continuing medical education (CME) program can change primary care providers' use of insulin therapy - their confidence in selecting doses and engagement of patients in the decision making as to whether to initiate insulin therapy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

25 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

International Diabetes Center

Minneapolis, Minnesota, 55416, United States

About this study

We will determine whether attendees' self-reported confidence and use of insulin with persons with type 2 diabetes changes after they attend the CME program. Specifically, we will address the following questions:

Question 1. Clinical guidelines. Is insulin initiated earlier (at a lower A1C)?

Question 2. Decision-making. Does confidence in selecting a starting insulin regimen change? Does confidence in selecting a starting insulin dose change? Does confidence in adjusting insulin change? Does confidence in discussion nutrition guidelines change?

Question 3. Application. Do more patients start using insulin? Who usually selects starting dose? How is starting dose selected? How often is insulin adjusted?

Question 4. Resources. How available are protocols for insulin use? How available is adequate time to monitor insulin therapy? How available is staff to teach insulin injections? How available is staff to help adjust insulin?

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • primary care provider attending CME training

Exclusion criteria

-

Treatment and study plan

Primary outcomes

  1. We will determine whether attendees' self-reported confidence and use of insulin with persons with type 2 diabetes changes after they attend the CME program.

    Time frame: pre program survey & 2-4 month post program survey

Secondary outcomes

  1. pre-CME training level of patient's A1c when starting insulin therapy compared to post-CME training level of patient's A1c when starting insulin therapy

    Time frame: pre program survey and 2-4 month post program survey

Sponsors and collaborators

Lead sponsor

HealthPartners Institute

Other

Collaborators

  • Eli Lilly and Company
  • International Diabetes Center at Park Nicollet
  • Merck Sharp & Dohme LLC
  • Novo Nordisk A/S
  • United Health Care

Registry information

Official study title

Impact of CME Program on Self-Reported Confidence and Use of Insulin in Persons With Type 2 Diabetes

Important dates

Study start
2006
Primary completion
2009
Study completion
2009
First posted
Jan 19, 2009
Registry last updated
Dec 2, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.